[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368043-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368043-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","detecting-glutathione-and-related-antioxidants-as-biomarkers-in-patient-breast-tumor-tissues-an-update-in-the-age-of-metabolomics","Detecting Glutathione and Related Antioxidants as Biomarkers in Patient Breast Tumor Tissues: An Update in the Age of Metabolomics","","Glutathione (GSH) and related antioxidant processes are reviewed as predictors of breast tumor aggressiveness and therapy response. Earlier synthesis of 21 studies reported higher GSH in tumors than in peritumoral tissue but no consistent links to grade, stage, or outcome. This update compiles 59 studies measuring 10 metabolites via metabolomics, noting that modern workflows often fail to fully prevent oxidation during tissue handling. Evidence indicates antioxidant/metabolite elevations in tumor tissue, and higher GSH with lower taurine associates with poorer patient outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/detecting-glutathione-and-related-antioxidants-as-biomarkers-in-patient-breast-tumor-tissues-an-update-in-the-age-of-metabolomics/368043/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/detecting-glutathione-and-related-antioxidants-as-biomarkers-in-patient-breast-tumor-tissues-an-update-in-the-age-of-metabolomics/368043.png","ImageObject",300,407,{"name":42,"@type":43},"hdkawk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is glutathione (GSH) considered a cancer-related biomarker?","Question",{"text":63,"@type":64},"Proliferating and cancerous tissues show a highly reduced intracellular environment reflected by the GSH-to-GSSG redox ratio. Altered GSH metabolism is suggested as a common cancer marker and can connect oxidative conditions to cell differentiation and death.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What did the earlier 2012 review find about GSH levels and patient outcomes?",{"text":68,"@type":64},"Most patient breast tumors displayed increased GSH compared with peritumoral tissue, but the data did not show a clear relationship between GSH levels and histological grade, clinical stage, or patient outcome.",{"name":70,"@type":61,"acceptedAnswer":71},"What changes in metabolomics methods motivated this update?",{"text":72,"@type":64},"Since 2012, metabolomics study numbers increased markedly and newer technologies profile multiple metabolites beyond GSH. However, many methods are not designed to prevent oxidation during tissue procurement and processing, which affects antioxidant measurement reliability.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368043,1790308205,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Wiley  \nOxidative Medicine and Cellular Longevity Volume 2025, Article ID 1811206, 20 pages [https://doi.org/10.1155/omcl/1811206](https://doi.org/10.1155/omcl/1811206)  \nReview Article  \nDetecting Glutathione and Related Antioxidants as Biomarkers in Patient Breast Tumor Tissues:  \nAn Update in the Age of Metabolomics  \nMichael P. Gamcsik   \nLampe UNC/NCSU Joint Department of Biomedical Engineering, North Carolina State University, Raleigh, North Carolina, USA Correspondence should be addressed to Michael P. Gamcsik; [mgamcsi@ncsu.edu](mgamcsi@ncsu.edu)  \nReceived 12 September 2025; Revised 26 October 2025; Accepted 3 November 2025  \nAcademic Editor: Dario Ramirez  \nCopyright © 2025 Michael P. Gamcsik. Oxidative Medicine and Cellular Longevity published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nIncreased levels of glutathione (GSH) and related antioxidant processes are thought to predict breast tumor aggressiveness and therapy response. In our 2012 review of 21 studies, we found that most patient breast tumors exhibited increased GSH levels compared to peritumoral tissue. However, there was no clear relationship between GSH levels and histological grade, clinical stage, or patient outcome. For this update, database searches found 59 studies that reported the levels of any of 10 metabolites, including GSH, cysteine (Cys), ascorbate (Asc), and taurine (Tau), in breast tumor tissues. The increase in the number of studies proﬁling tumor metabolites is mainly due to the use of an array of relatively new metabolomics technologies. However, many of these metabolomics methods are not designed to prevent sample oxidation during tissue procurement and processing. Despite this, these recent studies conﬁrm that the levels of most of the antioxidants or related metabolites are increased in patient breast tumor tissues compared to normal tissues. In addition, poor patient outcomes are often associated with tumor tissues with higher GSH and lower Tau levels. GSH levels also increase with histological grade. There are no clear trends in the relationship between any of the antioxidant levels and tumor stage or genetically deﬁned subtypes. Clearer trends may emerge with more uniform tissue sampling, preparation, and assay procedures. In addition, the increased use of spatial metabolomics methods may help to clarify the relationship between antioxidant levels and clinical markers.  \nKeywords: ascorbate; biomarker; breast cancer; glutathione; patients; taurine  \n1. Introduction  \nAll proliferating tissues, whether healthy or cancerous, display a highly reduced intracellular environment, which is reﬂected in the high reduced-to-oxidized (redox) ratio of the levels of glutathione (GSH) to its oxidized disulﬁde (GSSG) [1, 2]. These observations suggest that altered GSH metabolism is a common marker of cancer. A reduction in this ratio, for example, caused by an increasingly oxidative environment, can lead to cellular differentiation and ultimately cell death [1–3] . Many cancer therapies directly or indirectly alter the redox balance by inducing oxidative stress, which results in cell death [4–6]. It has long been hypothesized that the resistance of cancer cells to these therapies can be linked to increased levels of  \nantioxidant proteins and small molecules [7, 8]. We summarizedmany ofthese studies in2012and found that most human solid tumors do indeed display altered GSH metabolism relative to healthy tissues [9]. However, the relationship between GSH levels, tumor aggressiveness, and patient outcomes was not clear from the data presented in those studies. Since that review, the analytical methods and technologies that produce much of the clinical data on GSH levels have changed. The more recent molecular biomarker screenings of patient tumors utilize one or se","cbCaifnWl3bkG0gu","https://ap.wps.com/l/cbCaifnWl3bkG0gu","pdf",659424,"English","# Introduction\n## Redox balance and glutathione metabolism in cancer\n## Therapies, oxidative stress, and antioxidant resistance\n## Advances in metabolomics and biomarker screening\n# Literature selection and study inclusion\n## Database searching and record screening\n## Exclusion criteria and remaining study set\n## Flowchart of the selection process","[{\"question\":\"Why is glutathione (GSH) considered a cancer-related biomarker?\",\"answer\":\"Proliferating and cancerous tissues show a highly reduced intracellular environment reflected by the GSH-to-GSSG redox ratio. Altered GSH metabolism is suggested as a common cancer marker and can connect oxidative conditions to cell differentiation and death.\"},{\"question\":\"What did the earlier 2012 review find about GSH levels and patient outcomes?\",\"answer\":\"Most patient breast tumors displayed increased GSH compared with peritumoral tissue, but the data did not show a clear relationship between GSH levels and histological grade, clinical stage, or patient outcome.\"},{\"question\":\"What changes in metabolomics methods motivated this update?\",\"answer\":\"Since 2012, metabolomics study numbers increased markedly and newer technologies profile multiple metabolites beyond GSH. However, many methods are not designed to prevent oxidation during tissue procurement and processing, which affects antioxidant measurement reliability.\"}]","Detecting Glutathione and Related Antioxidants as Biomarkers in Patient Breast Tumor Tissues: An Update in the Age of Metabolomics | PDF",1790174600,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c5f6572941e4e6118b07658dd736c3d5.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3709c2041d9e09ac87233d542b9a4128.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa4c9dcb01819bc23ad9d751cef5118e.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77c62b6d1c2c8ad5849782ed271afe2e.webp",980,1306]